News

BIOTRONIK, a leading manufacturer of innovative medical technology, has launched its new online Travel Guide. With just a few clicks, patients with implanted BIOTRONIK cardiac devices such as pacemakers, implantable...

Cardiome Pharma Corp. and Merck, known as MSD outside the United States and Canada, announced that Merck will return the global marketing and development rights for both the intravenous (IV) and oral formulations for vernakalant to Cardiome....

RELIANCE® 4-FRONT™ Lead Designed to Streamline Surgical Procedure for Treatment of Heart Failure and Sudden Cardiac Arrest Boston Scientific Corporation has received regulatory approval to market the RELIANCE® 4-FRONT™ lead, its next...

Bristol-Myers Squibb and Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that ELIQUIS® (apixaban) be granted approval for...

Cardiome Pharma Corp. is pleased to announce the appointment of Jennifer Archibald as Chief Financial Officer (CFO) of the company, following the resignation of Curtis Sikorsky. Mr. Sikorsky will continue to serve the company in a consulting...

Sentara Heart Hospital is leading the way in an innovative atrial fibrillation (AF) procedure for what is typically the most difficult to treat or persistent forms of AF. This past week, surgeons and cardiologists at Sentara Heart Hospital...

Innovative Breakthrough for Implantable Cardiac Device Patients in the UK BIOTRONIK, a leading global manufacturer of innovative medical technology, is showcasing its new ProMRI® portfolio, BIOTRONIK Home Monitoring® and future technologies...

IMPROVE Brady Study Aims to Improve Adoption of Treatment Guidelines in Emerging Markets MINNEAPOLIS - September 20, 2012 - Medtronic, Inc. today announced the first patient enrollment in the IMPROVE Brady (Registry to Improve the Adoption...

Transgenomic, Inc. (TBIO) announced the appointment of Mark P. Colonnese as Executive Vice President and Chief Financial Officer of the Company. In this role, Mr. Colonnese will lead the Company’s financial and capital markets strategy, as...